Exact Mass: 265.20416819999997
Exact Mass Matches: 265.20416819999997
Found 155 metabolites which its exact mass value is equals to given mass value 265.20416819999997,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Acridine orange
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes D009676 - Noxae > D009153 - Mutagens
Mirtazapine
Mirtazapine is an antidepressant introduced by Organon International in 1996 used for the treatment of moderate to severe depression. Mirtazapine has a tetracyclic chemical structure and is classified as a noradrenergic and specific serotonergic antidepressant (NaSSA). It is the only tetracyclic antidepressant that has been approved by the Food and Drug Administration to treat depression. [Wikipedia] D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants CONFIDENCE standard compound; EAWAG_UCHEM_ID 3622 CONFIDENCE standard compound; INTERNAL_ID 1551 (R)-Mirtazapine ((R)-Org3770) is a R(?)-enantiomer of Mirtazapine with antinociceptive properties in an animal model of acute thermal nociception. (R)-Mirtazapine is a 5-HT3 receptor antagonist. (R)-Mirtazapine is mainly metabolized by CYP3A4[1]. Mirtazapine (Org3770) is a potent and orally active noradrenergic and specific serotonergic antidepressant (NaSSA) agent. Mirtazapine is also a 5-HT2, 5-HT3, histamine H1 receptor and α2-adrenoceptor antagonist with pKi values of 8.05, 8.1, 9.3 and 6.95, respectively[1][2].
5-Fluoro-8-hydroxy-2-(dipropylamino)tetralin
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists
Oxprenolol
Oxprenolol is only found in individuals that have used or taken this drug. It is a non-selective beta blocker with some intrinsic sympathomimetic activity. It is used for the treatment of angina pectoris, abnormal heart rhythms, anxiety, and high blood pressure. Oxprenolol is a lipophilic beta blocker which passes the blood-brain barrier more easily than water-soluble beta blockers. As such, it is associated with a higher incidence of CNS-related side effects than beta blockers with more hydrophilic molecules such as atenolol, sotalol, and nadolol (Wikipedia). Like other beta-adrenergic antagonists, oxprenolol competes with adrenergic neurotransmitters such as catecholamines for binding at sympathetic receptor sites. Like propranolol and timolol, oxprenolol binds at beta(1)-adrenergic receptors in the heart and vascular smooth muscle, inhibiting the effects of the catecholamines epinephrine and norepinephrine and decreasing heart rate, cardiac output, and systolic and diastolic blood pressure. It also blocks beta-2 adrenergic receptors located in bronchiole smooth muscle, causing vasoconstriction. By binding beta-2 receptors in the juxtaglomerular apparatus, oxprenolol inhibits the production of renin, thereby inhibiting angiotensin II and aldosterone production. Oxprenolol, therefore, inhibits the vasoconstriction and water retention due to angiotensin II and aldosterone, respectively. C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
Antazoline
Antazoline is only found in individuals that have used or taken this drug. It is a 1st generation antihistamine that also anticholinergic properties used to relieve nasal congestion and in eye drops, usually in combination with naphazoline, to relieve the symptoms of allergic conjunctivitis.Antazoline binds to the histamine H1 receptor. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine. R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents Antazoline (Phenazoline) is an H1 receptor antagonist that affects the activity of the central nervous system, has a potent antiarrhythmic effect[1][2][3].
4-Hydroxy-alprenolol
4-Hydroxy-alprenolol is a metabolite of alprenolol. Alprenolol, or alfeprol, alpheprol, and alprenololum (Gubernal, Regletin, Yobir, Apllobal, Aptine, Aptol Duriles), is a non-selective beta blocker as well as 5-HT1A receptor antagonist, used in the treatment of angina pectoris. It is no longer marketed by AstraZeneca, but may still be available from other pharmaceutical companies or generically. (Wikipedia)
Desmethylsibutramine
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D019440 - Anti-Obesity Agents > D001067 - Appetite Depressants
Mebeverine alcohol
C16H27NO2 (265.20416819999997)
3-formamido-7,8-epoxy-alpha-bisabolane|N-(trans-1-methyl-4-[(2R*,3R*)-2-methyl-3-[(1E)-3-methylbut-1-en-1-yl]oxiran-2-yl]cyclohexyl)formamide
C16H27NO2 (265.20416819999997)
(9aS)-6t-furan-3-yl-3,9c-dimethyl-(9ar)-octahydro-quinolizine-3c,4xi-diol|Deoxynupharidin-6,7ss-diol|deoxynupharidine-6xi,7-diol
3-formamidobisabolane-14(7),9-dien-8-ol
C16H27NO2 (265.20416819999997)
dodeca-6-keto-2E,4E-dienoic acid isobutylamide
C16H27NO2 (265.20416819999997)
6-furan-3-yl-2-(3-methoxy-3-methyl-butyl)-3-methyl-piperidine|Nupharamin-methylaether
C16H27NO2 (265.20416819999997)
tetradecahydro-dipyrido[2,1-f;2,3-h][1,6]naphthyridin-8a-ol
8beta-amino-10beta-hydroxyeremophyl-7(11)-en-12,8alpha-olide|rel-(4aR,5S,8aS,9aS)-9a-amino-4a,5,6,7,8,8a,9,9a-octahydro-8a-hydroxy-3,4a,5-trimethylnaphtho[2,3-b]furan-2(4H)-one
oxprenolol
C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 3128 CONFIDENCE standard compound; INTERNAL_ID 2209
mirtazapine
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants Mirtazapine (Org3770) is a potent and orally active noradrenergic and specific serotonergic antidepressant (NaSSA) agent. Mirtazapine is also a 5-HT2, 5-HT3, histamine H1 receptor and α2-adrenoceptor antagonist with pKi values of 8.05, 8.1, 9.3 and 6.95, respectively[1][2].
antazoline
R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents Antazoline (Phenazoline) is an H1 receptor antagonist that affects the activity of the central nervous system, has a potent antiarrhythmic effect[1][2][3].
Mebeverine metabolite (1-Butanol, 4-[ethyl[2-(4-methoxyphenyl)-1-methylethyl]amino]-)
C16H27NO2 (265.20416819999997)
Coretal
C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
(2R,6R,7S,8S)-7-(but-3-en-1-yl)-2-propyl-1-azaspiro[5.5]undecan-8-ol
(5R)-6-((8S,Z)-8-hydroxy-8-methylhexahydroindolizin-6(5H)-ylidene)-5-methylhexan-2-one
C16H27NO2 (265.20416819999997)
(6R)-6-methyl-7-((8R,Z)-8-methylhexahydroindolizin-6(5H)-ylidene)heptan-2-ol
(Z)-6-((R)-2-methyloctylidene)octahydroindolizin-8-ol
(1S,Z)-1-methyl-3-((R)-2-methylhexylidene)octahydro-2H-quinolizin-1-ol
((2S,3S,4R,7S,10S)-3,4,7,10-tetramethyldodecahydrocyclopenta[b]quinolizin-2-yl)methanol
Micropine
C16H27NO2 (265.20416819999997)
4-methoxy-3-(triisopropylsilyl)pyridine
C15H27NOSi (265.18618119999996)
4-amino-N-[2-(diethylamino)ethyl]-2-methoxybenzamide
2-(6-methyl-2-p-tolyl-imidazo[1,2-a]pyridin-3-yl)-ethylamine
2-(4-aminophenyl)-3-[4-(dimethylamino)phenyl]propanenitrile
1,1,1-Trimethyl-N-phenethyl-N-(trimethylsilyl)silanamine
2-methylpropyl 1-(furan-2-ylmethyl)piperidine-4-carboxylate
5-TERT-BUTYL-2-PIPERIDIN-1-YLMETHYL-FURAN-3-CARBOXYLIC ACID
5-TERT-BUTYL-2-METHYL-4-PYRROLIDIN-1-YLMETHYL-FURAN-3-CARBOXYLIC ACID
1,2-BENZENEDIOL, 4-[2-(DIBUTYLAMINO)ETHYL]-, HYDROBROMIDE
C16H27NO2 (265.20416819999997)
Etilefrine pivalate
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent
2-(dimethylamino)ethanol,prop-2-enoic acid,styrene
3-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRAZOL-1-YL)PROPANAMIDE
3-Azaspiro[5.5]undec-7-ene-3-carboxylic acid, 9-oxo-, 1,1-diMethylethyl ester
TERT-BUTYL (4-HYDROXY-2-PHENYLBUTAN-2-YL)CARBAMATE
2-(6,7-diethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)ethanol
5-isobutyl-2-methyl-4-pyrrolidin-1-ylmethyl-furan-3-carboxylic acid
N-[(2,3,4-trimethoxyphenyl)methyl]cyclopentanamine
2,2,6,6-Tetramethyl-1,2,3,6-tetrahydro-4-pyridineboronic acid pinacol ester
4-(4(5)-Methyl-1H-imidazol-2-yl)-piperidine-1-carboxylic acid tert-butyl ester
N-methyl-1-(3,4,5-trimethoxyphenyl)pent-4-en-2-amine
3-fluoro-N,N-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
C14H21BFNO2 (265.16492880000004)
2-((5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl)amino)ethanol
N,N-Dimethyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)ethanamine
N-(2-(diethylamino)ethyl)-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide
Esmirtazapine
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist (S)-Mirtazapine ((S)-Org3770) is a S(+)-enantiomer of Mirtazapine with pronociceptive properties in an animal model of acute thermal nociception. (S)-Mirtazapine is a stereoselective 5-HT2 receptor antagonist. (S)-Mirtazapine is metabolized by CYP2D6 and CYP1A2[1].
Neramexane mesylate
C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent
4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]-3-prop-2-enylphenol
(3R,4R,5R)-5-(hydroxymethyl)-1-(3-phenylpropyl)piperidine-3,4-diol
(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol
[(2S)-6-azaniumyl-1-oxo-1-[[(2S)-1-phenylpropan-2-yl]amino]hexan-2-yl]azanium
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators
16-Hydroxy-7-aza-15-azoniatetracyclo[7.7.1.02,7.010,15]heptadecan-6-one
(2E,6E,10R)-10,11-epoxy-3,7,11-trimethyltrideca-2,6-dienoate
(12R)-12-hydroxy-7-aza-15-azoniatetracyclo[7.7.1.02,7.010,15]heptadecan-6-one
(R)-Mirtazapine
(R)-Mirtazapine ((R)-Org3770) is a R(?)-enantiomer of Mirtazapine with antinociceptive properties in an animal model of acute thermal nociception. (R)-Mirtazapine is a 5-HT3 receptor antagonist. (R)-Mirtazapine is mainly metabolized by CYP3A4[1].
17-Hydroxylupanine(1+)
An organic cation that is the conjugate acid of 17-hydroxylupanine, arising from protonation of the hemiaminal nitrogen; major species at pH 7.3.
1-(Tert-butylamino)-3-(2,4,6-trimethylphenoxy)-2-propanol
C16H27NO2 (265.20416819999997)
6-{(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}hexanoate
1-[(E)-(6,6-Dimethyl-2-bicyclo[3.1.1]hept-2-enyl)methylideneamino]-3-propan-2-ylthiourea
(2E,6E,10R,11S)-10,11-epoxy-3,7,11-trimethyltrideca-2,6-dienoate
Conjugate base of (2E,6E,10R,11S)-10,11-epoxy-3,7,11-trimethyltrideca-2,6-dienoic acid.
2-Butoxy-N-(2-(ethylamino)ethyl)-3-pyridinecarboxamide
Acridine orange
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes D009676 - Noxae > D009153 - Mutagens
UH-301
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists
5-{5-hydroxy-6-methyl-4-oxatricyclo[3.3.1.0²,⁷]nonan-2-yl}-2-methylpent-2-enimidic acid
n-{4-[6-oxo-5-(sec-butyl)-1h-pyrazin-2-yl]butyl}ethanimidic acid
(7as)-1-hydroxy-2-octanoyl-5,6,7,7a-tetrahydropyrrolizin-3-one
(2e)-5-[(1s,3s,6r,9s)-6-(hydroxymethyl)-7-oxatricyclo[4.3.0.0³,⁹]nonan-9-yl]-2-methylpent-2-enimidic acid
15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecane-11,12-diol
C16H27NO2 (265.20416819999997)
(1s,2r,10s,11r,13r,15s)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecane-11,13-diol
C16H27NO2 (265.20416819999997)
7-oxa-5-azatetracyclo[7.7.1.0¹,¹².0⁵,¹⁷]heptadecan-11-ylmethanol
C16H27NO2 (265.20416819999997)
6-(dimethylamino)-1-(4-hydroxy-3-methoxyphenyl)hexan-1-one
(1s,2s,3s,6s,8r)-1,4,4-trimethyl-11-methylidene-9-azatricyclo[6.3.1.0²,⁶]dodec-9-ene-3,8,10-triol
6-(furan-3-yl)-3,9-dimethyl-octahydroquinolizine-3,4-diol
(1r,12s,16r)-14-methyl-10-oxo-5-azatricyclo[10.4.0.0⁵,¹⁶]hexadecan-5-ium-5-olate
C16H27NO2 (265.20416819999997)
n-(4-{5-[(2r)-butan-2-yl]-6-oxo-1h-pyrazin-2-yl}butyl)ethanimidic acid
(2e,4e)-n-(2-methylpropyl)trideca-2,4-dienimidic acid
(7z,10z)-5-propyl-1-oxa-4-azacyclopentadeca-7,10-dien-15-one
C16H27NO2 (265.20416819999997)
(2s,6z)-6-(aminomethylidene)-5-[(2r)-butan-2-yl]-2-ethyl-4-methoxy-2-methylcyclohex-4-ene-1,3-dione
(2e)-5-[(6s)-5-hydroxy-6-methyl-4-oxatricyclo[3.3.1.0²,⁷]nonan-2-yl]-2-methylpent-2-enimidic acid
(1r,2r,10s,11r,13s,14r,15s)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecane-11,14-diol
C16H27NO2 (265.20416819999997)
(1r,2r,4r,10s,11r,13s,15r)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecane-4,11-diol
C16H27NO2 (265.20416819999997)
(2e)-3-[(1r,4s,7s,9as)-1,7-dimethyl-octahydro-1h-quinolizin-4-yl]-4-oxobut-2-enoic acid
(4ar,5s,8as,9as)-9a-amino-8a-hydroxy-3,4a,5-trimethyl-4h,5h,6h,7h,8h,9h-naphtho[2,3-b]furan-2-one
(1r,2r,10s,11s,12s,13r,15r)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecane-11,12-diol
C16H27NO2 (265.20416819999997)
(2s)-6-(aminomethylidene)-5-[(2s)-butan-2-yl]-2-ethyl-4-methoxy-2-methylcyclohex-4-ene-1,3-dione
(1r,9r,11s,12r,17s)-7-oxa-5-azatetracyclo[7.7.1.0¹,¹².0⁵,¹⁷]heptadecan-11-ylmethanol
C16H27NO2 (265.20416819999997)
3-(1,7-dimethyl-octahydro-1h-quinolizin-4-yl)-4-oxobut-2-enoic acid
9a-amino-8a-hydroxy-3,4a,5-trimethyl-4h,5h,6h,7h,8h,9h-naphtho[2,3-b]furan-2-one
6-(dimethylamino)-1-(3-hydroxy-4-methoxyphenyl)hexan-1-one
6-(aminomethylidene)-2-ethyl-4-methoxy-2-methyl-5-(sec-butyl)cyclohex-4-ene-1,3-dione
(3r,4r,6s,9r,9as)-6-(furan-3-yl)-3,9-dimethyl-octahydroquinolizine-3,4-diol
1-methyl-2-{1-methyl-9h-pyrido[3,4-b]indol-4-yl}pyrrolidine
(5r,7z,10z)-5-propyl-1-oxa-4-azacyclopentadeca-7,10-dien-15-one
C16H27NO2 (265.20416819999997)
(1s,2s,10s,11s,12s,13s,15r)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecane-11,12-diol
C16H27NO2 (265.20416819999997)
(2e,4e)-n-[(2r)-2-methylbutyl]dodeca-2,4-dienimidic acid
5-[6-(hydroxymethyl)-7-oxatricyclo[4.3.0.0³,⁹]nonan-9-yl]-2-methylpent-2-enimidic acid
15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecane-11,13-diol
C16H27NO2 (265.20416819999997)
[(3s,5r,7as,11as)-5-butyl-decahydro-1h-pyrrolo[2,1-j]quinolin-3-yl]methanol
(1r,2r,10s,11s,12r,13r,15r)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecane-11,12-diol
C16H27NO2 (265.20416819999997)